Award
NIH Reporter #1K22AI192774-01
Therapeutically Targeting Kinases in KSHV Disease
Recipient
University of Nebraska Medical Center
Award Amount
$160,352.00
Ceiling
$160,352.00
Awarded
August 11, 2026
Identifier
1K22AI192774-01
Award for research on targeting ERBB kinases in KSHV disease to develop therapies for Kaposi’s sarcoma.
Description
The project focuses on understanding the role of ERBB kinases in KSHV reactivation and developing targeted therapies for Kaposi’s sarcoma.